期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
槐耳清膏对口腔鳞癌细胞SCC-15增殖、凋亡及侵袭能力影响的实验研究
1
作者 孙吉庆 李善昌 +2 位作者 马丽雨 李一国 张宏宇 《微量元素与健康研究》 CAS 2020年第2期10-12,共3页
目的:探究将槐,耳清膏加入到体外培养的口腔鳞癌细胞SCC-15中是否对其有抑制增殖、侵袭,并诱导其凋亡的作用。方法:采用MTT法分析不同浓度的(0.5 J.0,3.0,5.0,10.0 mg/ml)槐耳清膏加入口腔舞癌细胞中24 h,48 h后对其的增殖抑制作用。流... 目的:探究将槐,耳清膏加入到体外培养的口腔鳞癌细胞SCC-15中是否对其有抑制增殖、侵袭,并诱导其凋亡的作用。方法:采用MTT法分析不同浓度的(0.5 J.0,3.0,5.0,10.0 mg/ml)槐耳清膏加入口腔舞癌细胞中24 h,48 h后对其的增殖抑制作用。流式细胞仪分析槐,耳清膏作用24 h后口腔鳞癌SCC-15的凋亡情况。TRANSWELL法探究口腔鳞癌细胞侵袭能力的变化。结果:槐耳清膏作用于体外培养的口腔舞癌细胞,对其增殖能力具有显著的抑制作用.与药物浓度存在量效关系并随时间延长作用效果加强。槐耳清膏有促进口腔鳞癌细胞凋亡的作用。培养24 h后,浓度在0.5 mg/mg的槐耳清膏对细胞侵袭能力的影响无统计学意义,1.0,3.0.5.0,10.0 mg/ml槐耳清膏可以明显减低细胞的侵袭能力.浓度越高抑制作用越明显。结论:槐耳清膏能够降低体外培养口腔鳞癌细胞的增殖及侵袭能力并诱导细胞的凋亡。 展开更多
关键词 耳清膏 口腔鳞癌细胞 细胞增殖 细胞侵袭能力
原文传递
Anticancer Effect of PS-T on the Experimental Hepatocellular Carcinoma 被引量:6
2
作者 陈莉 陆正鑫 +1 位作者 陆鹏 李德生 《The Chinese-German Journal of Clinical Oncology》 CAS 2004年第1期55-59,67,68,共7页
Objective: To apply PS-T in di?erent phases of carcinoma formation and development, and research the mechanism of anti-carcinoma of PS-T in the cytological level. Methods: N-nitrosodiethylamine ... Objective: To apply PS-T in di?erent phases of carcinoma formation and development, and research the mechanism of anti-carcinoma of PS-T in the cytological level. Methods: N-nitrosodiethylamine (DENA) and CCl4 were applied jointly to duplicate the rat hepatocirrhosis and hepatic cancer model. The rats were divided into 7 groups and were administrated via nasal-stomach tube with PS-T in di?erent phases to interfere the cancer genesis and development. All the rats were killed in 20 weeks for pathological observation. Results: The loss of body weight of rats slowed down in the PS-T-treated group, and the carcinogenesis rate was signi?cantly decreased correspondingly. PS-T could also inhibit the carcinogenesis by supressing the hepatocirrhosis, which showed the positive correlation between the curative e?ect and the curative period. Conclusion: Application of PS-T during cancer induction showed a signi?cant e?ect on preventing and supressing cancer. PS-T might be an ideal drug for clinical anti-cancer therapy. And it will be a main drug in both combined and single treatments for tumor. 展开更多
关键词 PS-T hepatocellular carcinoma model hepatocirrhosis pathological change
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部